Body Mass Index News and Research

RSS

Men who enter adult life obese are at increased risk of premature death

Men who enter adult life obese face a life-long doubling of the risk of dying prematurely, new research has found.

13 Jul 2010

Intensive weight loss intervention program reduces hot flushes in overweight, obese women

Among overweight and obese women with bothersome hot flushes during menopause, an intensive weight loss intervention program may lead to improvements in flushing, according to a report in the July 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

13 Jul 2010

Weight loss related to fewer hot flashes in menopausal women: study

Hot flashes are an uncomfortable and distressing part of menopause that many women go through. Hot flashes also known as hot flushes are usually sudden sweatiness and redness in the face that can remain for four or five years into menopause. Now researchers have shown that losing weight may help reduce these symptoms.

13 Jul 2010

Obesity crisis in the spotlight as FDA reviews weight loss drugs

The Washington Post explores the obesity epidemic by reporting from Manchester, Ky., which has an obesity rate as high as 52 percent in a nation where the obesity rate is 24 percent. "The residents of this town of 2,100 — 95 miles southeast of Lexington and deep in the Appalachian foothills — indeed appear to celebrate the joys of community closeness.

13 Jul 2010

BCN launches Healthy Blue Living Rewards to improve overall health

Introducing Healthy Blue Living Rewards, an extension of Blue Care Network's successful Healthy Blue Living product. This new product is an innovative outcome-based HMO health care plan that takes personal accountability to the next level by lowering insurance costs for people who succeed in improving their health and thereby making health care more affordable.

13 Jul 2010

Study explores direct role of FTO gene on Alzheimer's and dementia risk in old age

A gene known as FTO, which appears to be correlated with obesity in humans, may also increase risk of Alzheimer's disease and dementia, according to new research presented today at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 in Honolulu, HI. And when a person has certain variants of both FTO and a recognized Alzheimer's risk gene known as APOE, the risk of Alzheimer's could be doubled.

13 Jul 2010

Researchers investigate impact of flavonols on stroke risk

New research has found that people who consume relatively high amounts of flavonols have a lower risk of stroke. Tea was most likely the major contributor of flavonols in the diet, ranging from 30 percent (US) to 70 percent (the Netherlands) of the total intake.

12 Jul 2010

Simple interventions by pediatricians change parent's perspective about child being overweight or obese

Some simple interventions used by pediatricians were enough to change a parent's perspective about a child's being overweight or obese, and change the parent's behaviors at home to reduce those risks.

12 Jul 2010

Namaste Charter School to use physical fitness and nutrition in childhood obesity prevention

At a time when the nation is focused on solving the problem of childhood obesity within a generation, and when school lunch revolutions are in full force - an inner city school in Chicago has found a winning formula. Namaste Charter School has a unique mission to use physical fitness and nutrition as avenues to reach higher student achievement, and this dedication to both academics and personal health has resulted in national recognition and a new, larger permanent home.

9 Jul 2010

Study shows association between obesity and GERD in children

Extremely obese children have a 40 percent higher risk of gastroesophageal reflux disease and children who are moderately obese have a 30 percent higher risk of GERD compared to normal weight children, according to a Kaiser Permanente study published online in the International Journal of Pediatric Obesity.

9 Jul 2010

Hormonal contraceptives are less effective for birth control in overweight or obese women: Study

As obesity continues to be a worldwide health risk, one of its "side effects" could include less effective birth control for overweight and obese women who use hormonal contraceptives.

9 Jul 2010

Research finds strong relationship between food environment, built environment and obesity

Researchers at the University at Buffalo conducting a neighborhood-scaled exploratory study that tested the association between the food environment, the built environment and women's body mass index (BMI) have found that women with homes closer to a supermarket, relative to a convenience store, had lower BMIs, and that the greater the number of restaurants within a five minute walk of a woman's home, the higher her BMI.

3 Jul 2010

WHO Fracture Risk Assessment Tool version 3.1 launched

The WHO Fracture Risk Assessment Tool (FRAX-) has today been launched in version 3.1., featuring eight new country models and accessible in six additional languages.

3 Jul 2010

Study results of triple combination therapy in patients with diabetes and hypertension presented at ADA 2010

Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].

1 Jul 2010

Eisai signs agreement with Arena Pharmaceuticals GmbH to commercialize lorcaserin

Eisai Inc., the U.S. pharmaceutical operation of Tokyo-based Eisai Co., Ltd., announced today that it has entered into an agreement with Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., for exclusive U.S. rights to commercialize lorcaserin, a drug candidate for potential use in the treatment of obesity, including weight loss, for patients who are obese (Body Mass Index or BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related co-morbid condition.

1 Jul 2010

Striking disparities persist; obesity rates highest among Blacks and Latinos

Adult obesity rates increased in 28 states in the past year, and declined only in the District of Columbia, according to F as in Fat: How Obesity Threatens America's Future 2010, a report from the Trust for America's Health and the Robert Wood Johnson Foundation.

30 Jun 2010

Nearly 7% of sixth-graders in U.S. are severely obese

Nearly 7 percent of sixth-graders across the U.S. are severely obese, reveals a new study appearing online in the Journal of Adolescent Health.

29 Jun 2010

Family members who undergo gastric bypass surgery together experience better clinical outcomes

If you and a family member have gastric bypass together, chances are you'll both do much better than if you have surgery alone, according to a new study presented today at the 27th Annual Meeting of the American Society for Metabolic & Bariatric Surgery.

29 Jun 2010

School-based program lowers obesity and risk factors for type 2 diabetes in high risk youth

An intervention in middle schools lowered the obesity rate in students at highest risk for type 2 diabetes, those who started out overweight or obese in sixth grade, an NIH-funded study has found. However, schools that implemented the program did not differ from comparison schools in the study's primary outcome-the prevalence of overweight and obesity combined-which had declined 4 percent in both groups of schools by the end of the three-year study.

29 Jun 2010

Clinical study results show no increased risk of CV events associated with SYMLIN injection

Amylin Pharmaceuticals, Inc. today announced results from an analysis of an integrated database of clinical studies that showed no increased risk of cardiovascular events associated with SYMLIN (pramlintide acetate) injection use compared to a pooled comparator group treated with either placebo or rapid-acting insulin. These findings were presented at the 70th Annual Scientific Sessions of the American Diabetes Association in Orlando, Fla.

28 Jun 2010

Body Mass Index News and Research

Men who enter adult life obese are at increased risk of premature death

Intensive weight loss intervention program reduces hot flushes in overweight, obese women

Weight loss related to fewer hot flashes in menopausal women: study

Obesity crisis in the spotlight as FDA reviews weight loss drugs

BCN launches Healthy Blue Living Rewards to improve overall health

Study explores direct role of FTO gene on Alzheimer's and dementia risk in old age

Researchers investigate impact of flavonols on stroke risk

Simple interventions by pediatricians change parent's perspective about child being overweight or obese

Namaste Charter School to use physical fitness and nutrition in childhood obesity prevention

Study shows association between obesity and GERD in children

Hormonal contraceptives are less effective for birth control in overweight or obese women: Study

Research finds strong relationship between food environment, built environment and obesity

WHO Fracture Risk Assessment Tool version 3.1 launched

Study results of triple combination therapy in patients with diabetes and hypertension presented at ADA 2010

Eisai signs agreement with Arena Pharmaceuticals GmbH to commercialize lorcaserin

Striking disparities persist; obesity rates highest among Blacks and Latinos

Nearly 7% of sixth-graders in U.S. are severely obese

Family members who undergo gastric bypass surgery together experience better clinical outcomes

School-based program lowers obesity and risk factors for type 2 diabetes in high risk youth

Clinical study results show no increased risk of CV events associated with SYMLIN injection

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News